NCT02863029View on ClinicalTrials.gov

Defining the Role of the Gut Microbiome in Mediating the Effects of Obesity on Intestinal Stem Cells

NATerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

March 9, 2017

Study Completion Date

March 9, 2017

Conditions
Obesity
Interventions
PROCEDURE

Flexible Sigmoidoscopy

A sigmoidoscopy is the minimally invasive medical examination of the large intestine from the rectum through the last part of the colon, using a flexible endoscope.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT02863029 - Defining the Role of the Gut Microbiome in Mediating the Effects of Obesity on Intestinal Stem Cells | Biotech Hunter | Biotech Hunter